Literature DB >> 32493679

Which symptoms negatively affect the oral health-related quality of life in patients with osteonecrosis of the jaw?

Takumi Sato1, Junya Kusunoto2, Daisuke Takeda2, Megumi Kishimoto1, Masahiko Kashin1, Shungo Furudoi3, Masaya Akashi4.   

Abstract

OBJECTIVES: One of the treatment goals for osteonecrotic lesions of the jaw, such as medication-related osteonecrosis of the jaw (MRONJ) or osteoradionecrosis (ORN), is restoration of quality of life (QOL). This study aimed to identify symptoms that negatively affect QOL in patients with unhealed MRONJ or ORN. STUDY
DESIGN: This cross-sectional study included patients who were previously diagnosed with MRONJ or ORN and who underwent treatment at the Kobe University Hospital between June 2015 and February 2016. Patient QOL was measured by using the Oral Health Impact Profile (OHIP-14). The predictor variable was disease status (stage and healing). The outcome variable was OHIP-14. One-way analysis of variance and Tukey's test were performed.
RESULTS: The study included 74 patients (37 men and 37 women; mean age 70 years). Although there was no significant difference between the OHIP-14 scores of unhealed MRONJ and ORN (stages 1-3) and those of healed ones, the "worsened sense of taste" resulted in significant differences among stages in patients with unhealed MRONJ (P = .027) and the "painful mouth aching" in patients with unhealed ORN (P = .041).
CONCLUSIONS: Worsened sense of taste and pain negatively affected QOL in patients with unhealed MRONJ and ORN.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32493679     DOI: 10.1016/j.oooo.2020.03.051

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  5 in total

1.  Surgical treatment of 61 consecutive patients with maxillary stage 3 medication-related osteonecrosis of the jaws using a pedicled buccal fat pad.

Authors:  Sanne Werner Moeller Andersen; Ditte Gertz Mogensen; Morten Schioedt; Thomas Kofod
Journal:  Oral Maxillofac Surg       Date:  2022-04-01

2.  Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics.

Authors:  Tomoya Soma; Ryotaro Iwasaki; Yuiko Sato; Tami Kobayashi; Eri Ito; Tatsuaki Matsumoto; Atsushi Kimura; Kana Miyamoto; Morio Matsumoto; Masaya Nakamura; Mayu Morita; Seiji Asoda; Hiromasa Kawana; Taneaki Nakagawa; Takeshi Miyamoto
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

3.  Referral to Pain Specialists for Treatment of Intractable Mandibular Pain Caused by Osteonecrosis of the Jaw: A Case Series Report.

Authors:  Yujiro Hiraoka; Megumi Matsumura; Kaito Uryu; Takumi Sato; Junya Kusumoto; Masaya Akashi
Journal:  Cureus       Date:  2022-06-21

Review 4.  The Therapeutic Effectiveness Using Fluorescence-Guided Surgery for MRONJ.

Authors:  Hongyuan Huang; Ning Zhao; Qingxiang Li; Qiao Qiao; Jianya Zhang; Chuanbin Guo; Yuxing Guo
Journal:  Biomed Res Int       Date:  2022-09-17       Impact factor: 3.246

5.  Oral-Health-Related Quality of Life in Patients with Medication-Related Osteonecrosis of the Jaw: A Prospective Clinical Study.

Authors:  Anna Winter; Stefan M Schulz; Marc Schmitter; Roman C Brands; Anton Straub; Alexander Kübler; Anna Borgmann; Stefan Hartmann
Journal:  Int J Environ Res Public Health       Date:  2022-09-16       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.